Activity and resistance of trastuzumab according to different clinical settings.

Activity and resistance of trastuzumab according to different clinical settings.

Item
http://www.wikidata.org/entity/Q37897395
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patientsPreclinical therapy of disseminated HER-2⁺ ovarian and breast carcinomas with a HER-2-retargeted oncolytic herpesvirus.Anti-IGF-1R monoclonal antibody inhibits the carcinogenicity activity of acquired trastuzumab-resistant SKOV3Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study.Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer.Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets.IL-15 enhances the anti-tumor activity of trastuzumab against breast cancer cells but causes fatal side effects in humanized tumor mice (HTM).Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge.Anti-HER3 Monoclonal Antibody Inhibits Acquired Trastuzumab-Resistant Gynecologic Cancers.Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody
P2860

Activity and resistance of trastuzumab according to different clinical settings.

Item
http://www.wikidata.org/entity/Q37897395
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activity and resistance of trastuzumab according to different clinical settings.
@en
Activity and resistance of trastuzumab according to different clinical settings.
@nl
type
label
Activity and resistance of trastuzumab according to different clinical settings.
@en
Activity and resistance of trastuzumab according to different clinical settings.
@nl
prefLabel
Activity and resistance of trastuzumab according to different clinical settings.
@en
Activity and resistance of trastuzumab according to different clinical settings.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Activity and resistance of trastuzumab according to different clinical settings
@en
P2093
P304
P31
P356
10.1016/J.CTRV.2011.06.002
P433
P478
P50
P577
P5875
P698